DRREDDY.NS
Dr.Reddy's Laboratories Ltd
Price:  
1,182.90 
INR
Volume:  
1,306,311.00
India | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DRREDDY.NS WACC - Weighted Average Cost of Capital

The WACC of Dr.Reddy's Laboratories Ltd (DRREDDY.NS) is 14.3%.

The Cost of Equity of Dr.Reddy's Laboratories Ltd (DRREDDY.NS) is 14.45%.
The Cost of Debt of Dr.Reddy's Laboratories Ltd (DRREDDY.NS) is 7.85%.

Range Selected
Cost of equity 13.30% - 15.60% 14.45%
Tax rate 24.30% - 26.80% 25.55%
Cost of debt 7.50% - 8.20% 7.85%
WACC 13.1% - 15.4% 14.3%
WACC

DRREDDY.NS WACC calculation

Category Low High
Long-term bond rate 6.9% 7.4%
Equity market risk premium 8.3% 9.3%
Adjusted beta 0.77 0.83
Additional risk adjustments 0.0% 0.5%
Cost of equity 13.30% 15.60%
Tax rate 24.30% 26.80%
Debt/Equity ratio 0.02 0.02
Cost of debt 7.50% 8.20%
After-tax WACC 13.1% 15.4%
Selected WACC 14.3%

DRREDDY.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for DRREDDY.NS:

cost_of_equity (14.45%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.77) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.